Shofu Dental Corp
$101.9K 106 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Brahms GmbH
Brahms GmbH reported $101,820.19 across General Payments, Research, and Ownership to 2 physicians and teaching hospitals across 3 transactions.
- $101.8K Below-median payer
- All-tracks total
- 3 Below-median volume
- Transactions
- 2 Below-median reach
- Recipients
- −$172.1K
- General Payments vs PY2023
Brahms GmbH reported $101,820.19 across all CMS Open Payments tracks (General + Research + Ownership) to 2 physicians and teaching hospitals in Program Year 2024 - ranking #1181 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $71,820.19, averaging $50.9K per recipient.
How Brahms GmbH's $101.8K all-tracks total breaks down
Brahms GmbH's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer brahms-gmbh Brahms GmbH
$101.8K · #1181/1,925 · 0.0% industry · PY2024
- TOT $101.8K
- RANK #1181
- SHARE 0.0%
- TXN 3
- RCP 2
- CAT 2
- GEN $71.8K
- ΔGEN −$172.1K
- TOP1 96.3%
- PY 2024
Volume peers
Nearest volume peer: Shofu Dental Corp ($101.9K)
Brahms GmbH sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Brahms GmbH's CMS-reported General Payments decreased by $172.1K (−70.6%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: BRAHMS GMBHPY2023: BRAHMS GMBHPY2024: Brahms GmbH. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $243,914.88
- PY2024
- $71,820.19
What the Data Shows for Brahms GmbH
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Brahms GmbH, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 2 general-payment categories charted below, "Royalty or License" is the largest at $69.2K across 1 transactions, 96.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Royalty or License" leads Brahms GmbH's 2-category general-payment breakdown at $69.2K, 96.3% of the reported total.
How Brahms GmbH divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $69.2K | 1 | 96.3% |
| Consulting Fee | $2.7K | 1 | 3.7% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $71,820.19 (100.0%) of $71,820.19 in this company's General Payments records across 2 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Brahms GmbH
The five named recipients with the highest reported General Payments from this company
- 1
Beth Israel Deaconess Medical Center
$69,160.19 across 1 reported transactions
- 2
Adrienne Randolph
$2,660.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Brahms GmbH ranks #1181 of 1,925 by total payments (bottom 39% by spend) but is notably more concentrated than that alone would suggest -- #164 of 1,838 by HHI (top 9% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Biolife, L.L.C. : $7.9K total payments, HHI 9454
- BSN Medical Inc : $445.4K total payments, HHI 9445
- VisionCare Inc. : $175.6K total payments, HHI 9376
- Ziemer USA : $62.1K total payments, HHI 9354
- AstraZeneca AB : $1.6M total payments, HHI 9332
- Synapse Biomedical Inc : $193.9K total payments, HHI 9301
- Brahms GmbH (this company) : $71.8K total payments, HHI 9287
- VisionAir Solutions, LLC : $81.4K total payments, HHI 9154
- Beyond Air, Inc. : $141.7K total payments, HHI 9142
- Vibrant Gastro, Inc. : $48.6K total payments, HHI 9128
- Sentynl Therapeutics, Inc. : $245.9K total payments, HHI 9110
- Hinge Health, Inc. : $20.8K total payments, HHI 9104
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Brahms GmbH's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Brahms GmbH.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Brahms GmbH.
Showing 6 of 1,924 companies with CMS-reported payment data.
BioPro, Inc.
$101.9K 145 recipients
Compare payment profiles
Kowa Pharmaceuticals America, Inc.
$101.9K 5,883 recipients
Compare payment profiles
Reapplix Inc.
$101.7K 318 recipients
Compare payment profiles
Actelion Pharmaceuticals, Ltd
$103.2K 55 recipients
Compare payment profiles
Forthright Medical - MT, LLC
$100.4K 51 recipients
Compare payment profiles
Put this to use
Brahms GmbH ranks #1181 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Brahms GmbH. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.